Can you provide the average price target for GENPACT LTD stock?
20 analysts have analysed G and the average price target is 49.83 USD. This implies a price increase of 33.05% is expected in the next year compared to the current price of 37.45.
NYSE:G • BMG3922B1072
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GENPACT LTD (G).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-10 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-02-06 | Needham | Maintains | Buy -> Buy |
| 2025-10-22 | Citigroup | Initiate | Neutral |
| 2025-08-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-08-08 | Needham | Maintains | Buy -> Buy |
| 2025-07-17 | Deutsche Bank | Reiterate | Hold |
| 2025-07-01 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-06-30 | Needham | Reiterate | Buy -> Buy |
| 2025-05-08 | Needham | Maintains | Buy -> Buy |
| 2025-05-08 | Baird | Maintains | Neutral -> Neutral |
| 2025-02-10 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-02-07 | Needham | Maintains | Buy -> Buy |
| 2025-01-21 | Jefferies | Upgrade | Hold -> Buy |
| 2024-11-11 | Needham | Maintains | Buy -> Buy |
| 2024-11-08 | TD Cowen | Maintains | Hold -> Hold |
| 2024-11-08 | Baird | Maintains | Neutral -> Neutral |
| 2024-10-09 | Baird | Maintains | Neutral -> Neutral |
| 2024-09-09 | Jefferies | Maintains | Hold -> Hold |
| 2024-09-06 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-08-12 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-08-09 | TD Cowen | Maintains | Hold -> Hold |
| 2024-08-09 | Needham | Maintains | Buy -> Buy |
| 2024-07-17 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2024-05-10 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-05-10 | Needham | Reiterate | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.477B 2.42% | 4.767B 6.48% | 5.08B 6.56% | 5.549B 9.23% | 5.952B 7.26% | 6.46B 8.53% | |
| EBITDA YoY % growth | 730.778M 6.53% | 798.315M 9.24% | 856.556M 7.30% | 1.068B 24.69% | 1.14B 6.74% | 1.278B 12.11% | |
| EBIT YoY % growth | 626.785M 12.63% | 702.061M 12.01% | 761.597M 8.48% | 972.86M 27.74% | 1.054B 8.34% | 1.145B 8.63% | |
| Operating Margin | 14.00% | 14.73% | 14.99% | 17.53% | 17.71% | 17.72% | |
| EPS YoY % growth | 2.98 8.36% | 3.21 7.72% | 3.66 14.02% | 4.10 11.94% | 4.53 10.48% | 5.15 13.87% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.94 11.91% | 0.99 12.92% | 1.06 9.73% | 1.10 13.57% | 1.04 10.98% | 1.11 11.53% | 1.18 10.57% | 1.22 10.34% | 1.15 9.98% | 1.32 18.73% | 1.31 11.36% | 1.37 12.45% |
| Revenue Q2Q % growth | 1.315B 8.24% | 1.368B 9.05% | 1.413B 9.43% | 1.452B 10.06% | 1.415B 7.60% | 1.469B 7.38% | 1.518B 7.43% | 1.552B 6.89% | 1.51B 6.71% | 1.585B 7.90% | 1.641B 8.10% | 1.682B 8.38% |
| EBITDA Q2Q % growth | 250.65M 22.32% | 263.17M 18.48% | 278.63M 3.85% | 287.4M -1.83% | 264.46M 5.51% | 277.14M 5.31% | 290.88M 4.40% | 300.52M 4.57% | 287.95M 8.88% | 304.16M 9.75% | 319.87M 9.97% | 329.66M 9.70% |
| EBIT Q2Q % growth | 227.92M 24.07% | 240.59M 34.11% | 254.1M 27.45% | 261.17M 32.03% | 246.31M 8.07% | 262.62M 9.16% | 274.3M 7.95% | 282.27M 8.08% | 262.47M 6.56% | 297.88M 13.43% | 296.48M 8.09% | 309.29M 9.57% |
All data in USD
20 analysts have analysed G and the average price target is 49.83 USD. This implies a price increase of 33.05% is expected in the next year compared to the current price of 37.45.
GENPACT LTD (G) will report earnings on 2026-05-05, after the market close.
The consensus EPS estimate for the next earnings of GENPACT LTD (G) is 0.94 USD and the consensus revenue estimate is 1.31B USD.
The consensus rating for GENPACT LTD (G) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.